Canadian generic drug prices 45% lower than PMPRB11 comparator countries’: CGPA reportThe average price of a brand name prescription in 2022 was $126, while the average price for a generic was $22, the report said. Persistence Capital Partners signs deal to take Neighbourly Pharmacy privateThe deal will see PCP, which already owns about a 50% interest in the network of independent pharmacies, pay $18.50 per share for a total of $415 million for the shares it does not already own. The pharmacist's guide to saying 'no' There are steps we must take, and assumptions we must reset, to reclaim our most precious resource: Time Older, immunocompromised people may get COVID-19 vaccine dose in spring, NACI says The advisory committee is issuing the spring recommendation now to help public health vaccine program planning. What was family medicine like in 2024? Dr. Adam Chen has a little chat with the Ghost of New Year Yet to Come and discovers what 2024 has in store. Women who take the pill are less likely to be depressed: study A new study of thousands of U.S. women shows that the prevalence of major depression is lower among those taking the birth control pill. Dichloroacetate shows promise for the treatment of endometriosis Phase 2 trial using DCA, typically used to treat metabolic disease, underway in the U.K. Two unnamed sources tell the Globe and Mail that Rexall is on the buyer’s block McKesson has neither confirmed nor denied that it's looking to unload Rexall, which it bought in 2016 for $2.9 billion. Anaphylaxis update focuses on seven areas with new evidence and recommendations Updated practice parameter evaluates current evidence and provides guidance to healthcare practitioners on the diagnosis and management of anaphylaxis. Prescribing safer alternatives to potentially deadly street drugs saved lives: B.C. study Those given a four-day or longer prescription cut their risk of death by 89%. First Previous 229 230 231 232 233 Next Last
